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The base-excision repair pathway has evolved to repair a diverse
range of base modifications and base losses as well as damage to
the sugar-phosphate backbone of DNA. This damage may arise
through spontaneous base hydrolysis (Lindahl and Anderson,
1972), endogenous oxidative metabolism (Lindahl, 1990), or expo-
sure to genotoxic agents, including agents that exert their effects
via the formation of reactive oxygen species, such as peroxides and
ionizing radiation (reviewed by Demple and Harrison, 1994).
The major cytotoxic lesion following exposure of cells to
ionizing radiation is considered to be the DNA double-strand break
(dsb) associated with other lesions in damage complexes termed
local-multiply (or regional)-damaged sites (Ward et al, 1994).
However, apurinic/apyrimidinic (AP) sites are major lesions
resulting from the direct effects of radiation on DNA bases or
following glycosylase-mediated excision of specific modified
bases. The action of AP endonucleases on these AP sites produces
single-strand breaks that are likely to contribute to the formation of
dsb if they are in close proximity to other lesions. Disruption of the
sugar-phosphate backbone of DNA also occurs causing strand
breaks with atypical termini (Teoule, 1987). These include 3¢ phos-
phate and 3¢-phosphoglycolate termini which cannot be used as
primers for DNA synthesis by Escherichia coli DNA polymerase I
or T4 DNA polymerase (Henner et al, 1983), since a 3¢ hydroxyl
terminus is required. Consequently, these 3¢ terminal modified
deoxyribose moieties constitute blocks to DNA repair synthesis.
If unrepaired, both AP sites and 3¢ blocked termini can be toxic
(Demple et al, 1986), and AP sites can also be mutagenic (Loeb
and Preston, 1986). The major cellular enzymes responsible for
initiating the repair of these sites are class II AP endonucleases
(reviewed by Doetsch and Cunningham, 1990; Demple and
Harrison, 1994; Barzilay and Hickson, 1995). AP endonucleases
incise the phosphodiester backbone 5¢ to the abasic site to generate
3¢ phosphate and 5¢ deoxyribose phosphate termini. Additionally,
the 3¢-diesterase activity processes blocked 3¢ termini to produce
3¢ hydroxyl termini (Demple and Harrison, 1994; Winters et al,
1994). The 5¢ deoxyribose phosphate group is excised by a
deoxyribose phosphodiesterase, giving 5¢ phosphate, and the
single nucleotide gap thus generated can be filled by a DNA poly-
merase and repair completed by a DNA ligase.
In human cells the major AP endonuclease is HAP1 (Robson
and Hickson, 1991); also termed APEX, APE and Ref-1 (Demple
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Summary Apurinic/apyrimidinic (AP) sites in DNA are potentially lethal and mutagenic. They can arise spontaneously or following DNA
damage from reactive oxygen species or alkylating agents, and they constitute a significant product of DNA damage following cellular
exposure to ionizing radiation. The major AP endonuclease responsible for initiating the repair of these and other DNA lesions in human cells
is HAP1, which also possesses a redox function. We have determined the cellular levels of this enzyme in 11 human tumour and fibroblast
cell lines in relation to clonogenic survival following ionizing radiation. Cellular HAP1 levels and surviving fraction at 2 Gy (SF2) varied five-
and tenfold respectively. However, no correlation was found between these two parameters following exposure to g-irradiation at low (1.1 cGy
per min) or high (108 cGy per min) dose rates. To examine this further, wild-type and mutant versions of HAP1 were overexpressed, using an
inducible HAP1 cDNA expression vector system, in the rat C6 glioma cell line which has low endogenous AP endonuclease activity. Induction
of wild-type HAP1 expression caused a > fivefold increase in the capacity of cellular extracts to cleave an oligonucleotide substrate containing
a single abasic site, but increased expression did not confer increased resistance to g-irradiation at high- or low-dose rates, or to the
methylating agent methyl methanesulphonate (MMS). Expression in C6 cell lines of mutant forms of HAP1 deleted for either the redox
activator or DNA repair functions displayed no apparent titrational or dominant negative effects. These studies suggest that the levels of
endogenous AP endonuclease activities in the various cell lines examined are not limiting for efficient repair in cells following exposure to
ionizing radiation or MMS. This contrasts with the correlation we have found between HAP1 levels and radiosensitivity in cervix carcinomas
(Herring et al (1998) Br J Cancer 78: 1128–1133), indicating that HAP1 levels in this case assume a critical survival role and hence that
established cell lines might not be a suitable model for such studies.
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et al, 1991; Seki et al, 1991; Xanthoudakis and Curran, 1992).
HAP1 possesses AP endonuclease, 3¢ phosphatase and 3¢ phos-
phodiesterase DNA repair activities and RNAase H activity
(reviewed in Barzilay et al, 1996; Rothwell et al, 1997). In addi-
tion, HAP1 has been shown to function as a ‘redox’ modifier,
facilitating the DNA binding of fos and jun, and other transcription
factors, through reductive activation (Xanthoudakis et al, 1992).
This activity may implicate HAP1 in a gene regulatory role, coor-
dinating cellular responses to oxidative and/or hypoxic stress.
HAP1 also is a potent activator of p53 by both redox-dependent
and -independent means, and it can stimulate p53 transactivation
in vivo (Jayaraman et al, 1997). The DNA repair and redox tran-
scriptional regulator functions of the enzyme are dependent upon
distinct active sites (Walker et al, 1993; Xanthoudakis et al, 1994).
The conserved amino acids Glu-96, Asp-283, His-309 and Asn-
212 are essential for efficient DNA repair activity (Barzilay et al,
1995a, 1995b; Rothwell and Hickson, 1996), while Cys-65 is
crucial for redox activity (Walker et al, 1993).
It is, therefore, not unreasonable to suggest that the activity of AP
endonucleases may contribute to cell survival following exposure to
ionizing radiation. However, the amounts of enzyme required to
deal with endogenously generated damage (see above) are likely to
be small in comparision to the amounts required to deal with the
substantial levels of damage from therapeutic doses of ionizing radi-
ation, and therefore normal expression levels might be expected to
be rate-limiting in the repair of AP sites in irradiated cells.
Several studies have shown that cellular depletion of HAP1
protein via expression of antisense HAP RNA sensitizes cells to
killing by a wide range of cytotoxic agents, including methyl
methanesulphonate (MMS) and peroxides (Ono et al, 1994; Walker
et al, 1994), the redox cycling drug menadione, the radiomimetic
agent bleomycin (Barzilay et al, 1996), and X-rays (Chen and
Olkowski, 1994). Also, a correlation between HAP1 levels and the
sensitivity of a series of glioma cell lines to MMS or hydrogen
peroxide was reported, using the dose for 50% survival as the sensi-
tivity parameter (Ono et al, 1995). In addition, there was a trend
towards a correlation between HAP1 levels and the sensitivity of the
same series of cell lines to X-rays. Although the correlation (r= 0.71)
was found to be not statistically significant (P = 0.11), a subsequent
re-analysis of the same published data, using the linear-quadratic
model and the alpha parameter as a measure of radiosensitivity,
produced a significant (P = 0.02) and higher degree of correlation (P
Lambin, personal communication). Furthermore, a correlation has
recently been demonstrated for the levels of HAP1 immunostaining
of cervical carcinoma sections and the in vitro radiosensitivity of
primary cells cultured from such tumours (r = 0.60, P = 0.002;
Herring et al, 1998). The possibility that HAP1 expression might be
used to contribute to the prediction of the clinical response of normal
and tumour tissues to radiotherapy encouraged investigation of the
possible contribution of HAP1 to the varying radiosensitivity
observed among a further series of human cell lines. In parallel,
radiation responses were also determined following overexpression
of wild-type and mutated HAP1 in a mammalian cell line with low
endogenous AP endonuclease activity.
MATERIALS AND METHODS
Normal cell lines
Du145 (human prostate carcinoma), WiDr (human colon adeno-
carcinoma), A2780 and HOC8 (human ovarian carcinoma),
Ms751 and ME180 (human cervical carcinoma), NB1-g and NB1-
clone F (human neuroblastoma), cells were cultured in basal modi-
fied Eagle’s medium (MEM) supplemented with 10% fetal calf
serum (FCS). The cell lines 350s, 351s and vag12 (normal human
fibroblast), were cultured in MEM with 15% FCS; and C6 (rat
glioma) cells in Dulbecco’s modified Eagle’s medium (DMEM;
Gibco) with 10% FCS. Cells were maintained in exponential
growth at 37°C in an atmosphere of 5% carbon dioxide.
Cells containing inducible wild-type or mutant HAP1
The HAP1 cDNA (or the mutated derivatives HAP1-C6SA and
HAP1-D283A; Walker et al, 1993; Barzilay et al, 1995a) was ampli-
fied using the polymerase chain reaction with 5¢and 3¢primers which
contain Not1 recognition sites. In addition, the 5¢ primer contained
the sequence coding for the c-myc epitope recognized by the 9E10
monoclonal antibody. Following digestion of the product with Not1,
the DNA was ligated into a Not1-digested pOPRSVICAT construct
(Stratagene). Clones containing the HAP1 cDNA in the correct
orientation were identified using diagnostic restriction digestion.
Stably-transfected rat glioma C6 cells were generated by co-
transfection with pOPRSVICAT/HAP1 and p3¢SS (which
expresses the lac repressor encoded by the lacl gene), and selec-
tion for resistance to both G418 (750 mg ml–1) and hygromycin
(20 mg ml–1). Cell clones which expressed HAP1 protein following
de-repression of the RSV promoter following addition of IPTG
(2 mM) were identified by immunoblotting of whole cell extracts.
Preparation of cell extracts
Following mechanical disruption of adherent monolayers, cells
were harvested by centrifugation (1000 rpm, 20°C, 7 min) and
washed twice in ice-cold PBS. Protein extracts for immunoblotting
were prepared by sonication in 50 mM Tris–HCl pH 8.3, 1 mM
EDTA, 3 mM dithiothreitol (DTT) and 1 mM leupeptin; phenyl-
methylsulphonyl fluoride (PMSF) was added to 1 mM, and cell
debris was removed by centrifugation (17 800 g, 4°C, 10 min).
Supernatants for AP endonuclease assay were prepared in 50 mM
Hepes-KOH, pH 7.5, 150 mM potassium chloride, 10% glycerol
and 1 mM DTT containing protease inhibitors (1 mg ml–1 aprotinin,
1 mg ml–1 pepstatin A, 1 mg ml–1 leupeptin A, 100 mg ml–1 PMSF)
by the same method. Protein concentration was estimated by
BioRad protein assay (BioRad), and DNA concentration by
Hoechst 33258 fluorimetry using a Hoefer TKO-100 Mini-fluo-
rimeter with excitation and detection wavelengths of 365 nm and
458 nm respectively. Extracts were stored at –80°C.
Immunoblotting analysis
Cell extracts were prepared as above and aliquots were resolved
by sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE) and electroblotted to Hybond C extra membranes
(Amersham). The blots were probed with a rabbit anti-HAP1 anti-
serum (Herring et al, 1998), and then incubated with goat:anti-
rabbit IgG conjugated with horseradish peroxidase (Dako).
Binding of secondary antibody was detected by enhanced chemi-
luminescence (Amersham) and exposure to X-ray film (RX, Fuji).
Band density was assessed using a UVP Imagestore 5000 system
(Ultraviolet Products Ltd, UK), and HAP1 protein was quantitated
by comparison with pure rHAP1 protein standards (0–8 ng).
HAP1 levels were expressed relative to cell extract DNA content.942 CJ Herring et al
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AP endonuclease assay
AP endonuclease activity was determined using an oligonucleotide
based assay, essentially as described previously (Winters et al,
1994). A 30-bp synthetic oligonucleotide (5¢-TCG GTA CCC GGG
GAU CCT CTA GAG TCG ACC-3¢), containing a single uracil
residue, was 5¢-32P end-labelled using T4-polynucleotide kinase
(PNK) and [g-32P]-ATP. Labelling efficiency was calculated by a
DE81 filter binding assay, and unincorporated isotope was removed
by Sephadex G-25 spun column chromatography. To create an AP
site, unlabelled oligonucleotide (100 pmol) was first mixed with
radiolabelled product (500–1000 cps) and then treated with 1 U
uracil DNA glycosylase (Boehringer Mannheim) in a buffer
containing 60 mM Tris–HCl, 1 mM EDTA, 1 mM DTT, 0.1 mg ml–1
BSA, pH 8.0, for 15 min at 37°C. The reaction was terminated by
heating at 80°C for 10 min, followed by ethanol precipitation.
Exposure of the oligonucleotide to 10% piperidine (90°C, 30 min),
PAGE and phosphorimage analysis (Molecular Dynamics, model
No. 425) confirmed the AP site status. The HAP1 substrate was
generated by annealing of the AP-oligonucleotide to an equimolar
quantity of a complementary 30 mer (5¢-GGT CGA CTC TAG
AGG TTC CCC GGG TAC CGA-3¢).
AP endonuclease activity was determined by incubation of cell
extract (equivalent to 0–30 ng DNA) with 5 pmol oligonucleotide
substrate in a total volume of 25 ml of 50 mM Tris–HCl, pH 8.0,
10 mM sodium chloride, 0.2 mM EDTA, 5 mM magnesium chloride
and 50 mg heat inactivated BSA for 5 min at 37°C. The reaction
was stopped by the addition of EDTA and proteinase K to 25 mM
and 50 mg ml–1, respectively, and heating at 42°C for 5 min.
Following ethanol precipitation, the oligonucleotide cleavage
product was resolved by denaturing PAGE, and quantitated by
phosphorimage analysis.
Clonogenic survival assay
In studies of the induction of wild-type or mutant HAP1 in C6
cells, C6HAP, C6HAP-C65 and C6HAP-D283 cells were treated
with 2.5 mM IPTG 24 h prior to g-irradiation. For low dose-rate
irradiation studies, cells growing as monolayers were exposed to
0–8 Gy using a 60Co source (1.12 cGy per min). Cells were then
trypsinized and seeded in triplicate on 6-cm plates at a dilution
estimated to give 100 colonies per plate for each dosage point. For
high dose-rate irradiation studies, cells were harvested prior to
irradiation (0–10 Gy) in suspension using a 137Cs source (312 cGy
per min). After culture for 8–10 days, colonies were fixed in 10%
formaldehyde and stained with 0.25% crystal violet before
counting. For MMS survival studies, cells were plated 6 h prior to
the addition of MMS (0–1.4 mM) and after 1 h exposure the
culture medium was replaced.
For human cell lines Du145, WiDr, A2780, HOC8, Ms751,
ME180, NB1-g, NB1-clone F, 350s, 351s and vag12, the surviving
fraction at 2 Gy (SF2) was determined as a parameter for compar-
ison of cellular radiosensitivity. Survival following low dose-rate
(60Co 1.12 cGy per min) or high dose-rate (108 cGy per min) irra-
diation was determined as above for C6 cells. Cells were cultured
for 10–20 days before staining and counting.
RESULTS
HAP1 expression and radiosensitivity in human cell
lines
There was no significant correlation between HAP1 expression, as
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Figure 1 Comparison between HAP1 protein levels and surviving fraction
at 2 Gy (SF2) using high and low dose-rate g-irradiation. HAP1 expression
was determined by western blot analysis and SF2 values were calculated
from clonogenic survival curves fitted using the DRFIT program (Roberts,
1990). Errors are ± s.e.m., n = 2–4. No correlation was seen between HAP1
expression and SF2 at high (r = 0.18, P = 0.54) or low dose-rate (r = 20.09,
P = 0.78). Cell lines are as follows: 1, A2780; 2, vag12; 3, 350s; 4, nb1-g;
5, ME180; 6, clone F; 7, 351s; 8, WiDr; 9, MS751; 10, HOC8; 11, Du145
38 kDa
0 6 12 24 48 72 h
Figure 2 Immunoblot analysis of HAP1 expression in C6 glioma cells stably
transfected with the inducible expression-construct pOPRSVICATHAP1.
Expression was induced by treatment of cells with IPTG (0.25 mM) for a
period of 0–72 h before harvesting. Cell extracts containing 30 mg protein
were analysed by immunoblotting and immunostaining using an anti-human
HAP1 specific rabbit serum as described in Materials and Methods. Induction
of the 38-kDa HAP1 protein was evident within 6 h, with high levels at
24–72 h after IPTG treatmentExpression levels of the DNA repair enzyme 943
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characterized by SF2 at either high (r = 0.18, P = 0.54) or low (r =
0.09,  P = 0.78) dose-rates (Figure 1). Low dose-rate sparing,
calculated by subtraction of the SF2 at high dose-rate from that at
low dose-rate for each cell line, also did not correlate well with
HAP1 expression (data not shown).
Effect of HAP1 and mutant HAP1 expression on C6
glioma survival
For C6 cells transfected with the HAP1 expression plasmid, induc-
tion of expression of the 38-kDa protein, as assessed by
immunoblotting analysis, was evident ~6 h after treatment with
IPTG (2.5 mM) and high levels were observed at 24–72 h (Figure
2). After removal of IPTG, HAP1 levels remained elevated for 48
h and could still be detected at 60 h, but decreased to near back-
ground levels after 80 h (data not shown). A period of 24 h
pretreatment with IPTG was used in subsequent survival studies.
In vitro assay of endogenous AP endonuclease activity in extracts
of non-induced control C6HAP cells indicated levels that were
74 ± 11% fmoles h–1 mg–1 DNA (s.d., two separate experiments) of
those in extracts of 351s cells which had the lowest HAP1 expres-
sion among the human cell lines. Following 24 h induction by
IPTG, C6HAP AP endonuclease activity was 7.1 ± 1.7-fold
(s.e.m., three separate experiments) higher than in non-induced
control populations, indicating that active human HAP1 was
produced in these cells. The results of a typical assay are shown in
Figure 3.
In clonogenic survival assays, induction of HAP1 did not result
in increased resistance to g-irradiation at either high or low dose-
rates, or to MMS (Figure 4). C65A and D283A mutant versions of
HAP1 have previously been characterized as lacking in redox and
DNA repair functions respectively (Walker et al, 1993; Barzilay et
al, 1995). Induction of expression of mutant HAP1 proteins on
treatment of C6HAP:C65A and C6HAP:D283A cells with IPTG
(2.5 mM, 24 h) was confirmed by immunoblotting (data not
shown), but these cells displayed no altered sensitivity to g-irradi-
ation at low dose-rates or to MMS (Table 1).
DISCUSSION
In the present study, we have related the amount of the major AP






































































Figure 3 AP endonuclease activity of C6 cells transfected with the
pOPRSVICATHAP1 construct (C6HAP1 cells), demonstrating inducible
HAP1 expression. C6HAP1 cells were cultured in the absence (l) or
presence (l l) of IPTG (0.25 mM, 24 h) and the ability of cell extracts to cleave
a 32P-labelled AP-site containing substrate was determined and expressed
relative to cell extract DNA content. Values are the mean of two
determinations ± s.d.
Figure 4 Survival of C6HAP1 cells following (A) high (l l, l), or low (n n, n)
dose-rate g-irradiation and (B) treatment with MMS (s s, s) for IPTG (0.25
mM, 24 h)-induced HAP1 expressing cells (open symbols) relative to non-
induced control populations (closed symbols). Points are the mean of at least
two independent experiments ± s.d.944 CJ Herring et al
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human tumour cell lines. HAP1 was chosen because it is the major
endonuclease acting on one of the most important consequences of
base damage to DNA, i.e. AP sites, following exposure to ionizing
radiation: the protein also displays a redox function that promotes
the binding of transcription factors to DNA, but the potential role
of this in radiosensitivity is not known.
We found no correlation between HAP1 levels and SF2 at either
low or high dose-rate among the range of human cell lines exam-
ined. This indicates that the levels of HAP1 are not predictive of
radiosensitivity among this set of cell lines of various tissue
origins, and therefore that, if HAP1 does contribute to cellular
protection against g-irradiation, its role must be relatively minor
compared to that of other repair systems.
In order to further address this point, we overexpressed HAP1 in
a rat cell line that was relatively deficient in endogenous AP
endonuclease activity, but this had no measurable effect on radia-
tion or MMS sensitivity. This is in contrast to an earlier report of a
decrease in radiation sensitivity in two radiosensitive murine cell
lines following transfection with a HAP1-encoding plasmid (Chen
et al, 1992). We therefore also examined the effects on sensitivity
to radiation or MMS of overexpression in the rat cell line of two
versions of HAP1 that contained inactivating mutations in either
the repair or the redox domains (Walker et al, 1993; Barzilay et al,
1995a), but neither had any significant effect on radiation or MMS
survival. Earlier work had indicated that the expression of E. coli
endonuclease III in Chinese hamster lung fibroblasts had no effect
on sensitivity to ionizing radiation, but it increased sensitivity to
the radiomimetic agent bleomycin sulphate, possibly as a conse-
quence of generating more DNA double-strand breaks by cleavage
at clustered AP sites (Harrison et al, 1992). On the other hand,
expression of endonuclease III in yeast has been shown recently to
increase radiation resistance (Skorvaga et al, unpublished data).
This was not the case with HAP1 in the present report and since
expression of the mutant HAP1 proteins had no detectable effect
on low-dose-rate radiosensitivity, it appears that they have no titra-
tional or dominant negative effects on endogenous AP endo-
nuclease activity.
Based on our observations, it is likely that levels of HAP1 do
not, in general, correlate with the radiosensitivity of a variety of
cell lines. Thus, apart from the enzymes recognizing base modifi-
cations and removing them by glycosylase action, the levels of
DNA polymerase and ligase might also be rate-limiting in the
repair of that radiation damage which has AP sites as intermedi-
ates. In addition, any of the many other factors that have been
implicated in defining radiosensitivity such as expression of or
mutation in ATM, DNA-PK, p53 and other gene products
(Yarnold, 1997) may individually or in combination define
survival following radiation. Whilst HAP1 may represent one
among many factors that are important in toxicity, its effects may
only become evident in specific circumstances and in a limited
number of cell types. The levels of HAP1 have been reported to be
6–20 times higher in established cell lines than in primary cells
(Chen et al, 1991; LaBelle and Linn, 1984), and HAP1 levels may
therefore be more critical in the latter. This would be consistent
with the significant correlation found between the levels of HAP1
expression detected in fixed tumour biopsies and the radiosensi-
tivity of cells primary-cultured from them (Herring et al, 1998).
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